# Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

> **NCT01959672** · PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 11 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma
- Resectable Pancreatic Carcinoma
- Stage I Pancreatic Cancer
- Stage IA Pancreatic Cancer
- Stage IB Pancreatic Cancer
- Stage II Pancreatic Cancer
- Stage IIA Pancreatic Cancer
- Stage IIB Pancreatic Cancer
- Stage III Pancreatic Cancer

## Interventions

- **PROCEDURE:** 4-Dimensional Computed Tomography
- **DRUG:** Fluorouracil
- **DRUG:** Gemcitabine Hydrochloride
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Leucovorin Calcium
- **DRUG:** Nelfinavir Mesylate
- **BIOLOGICAL:** Oregovomab
- **RADIATION:** Stereotactic Body Radiation Therapy
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT01959672
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-06
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01959672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01959672, "Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01959672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*